Managing erectile dysfunction in hypertensive patients

J Clin Hypertens (Greenwich). 2011 Jun;13(6):450-4. doi: 10.1111/j.1751-7176.2011.00465.x. Epub 2011 Apr 22.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Amides / adverse effects
  • Amides / therapeutic use
  • Antihypertensive Agents / adverse effects*
  • Antihypertensive Agents / therapeutic use
  • Benzopyrans / adverse effects
  • Benzopyrans / therapeutic use
  • Chlorthalidone / adverse effects
  • Chlorthalidone / therapeutic use
  • Ethanolamines / adverse effects
  • Ethanolamines / therapeutic use
  • Fumarates / adverse effects
  • Fumarates / therapeutic use
  • Humans
  • Hydrochlorothiazide / adverse effects
  • Hydrochlorothiazide / therapeutic use
  • Hypertension / drug therapy*
  • Hypertension / pathology
  • Impotence, Vasculogenic / chemically induced
  • Impotence, Vasculogenic / drug therapy*
  • Impotence, Vasculogenic / pathology
  • Losartan / adverse effects
  • Losartan / therapeutic use
  • Male
  • Middle Aged
  • Nebivolol
  • Risk Factors

Substances

  • Amides
  • Antihypertensive Agents
  • Benzopyrans
  • Ethanolamines
  • Fumarates
  • Nebivolol
  • Hydrochlorothiazide
  • aliskiren
  • Losartan
  • Chlorthalidone